Related Experiment Videos
[Left ventricular remodeling: pathophysiological mechanisms and therapeutic recommendations]
Zeitschrift Fur Kardiologie
|February 2, 2000
Summary
Angiotensin-converting enzyme (ACE) inhibitors significantly reduce mortality after myocardial infarction, especially in patients with heart failure. Early, selective ACE inhibitor use offers substantial survival benefits, yet clinical adoption remains suboptimal.
Area of Science:
- Cardiology
- Cardiovascular Physiology
- Pharmacology
Context:
- Hospital mortality from acute myocardial infarction (AMI) has declined.
- Left ventricular dysfunction post-AMI is primarily linked to ischemia.
- Myocardial remodeling alters left ventricular geometry, impacting neurohormonal systems and cardiac structure.
Purpose:
- To review the impact of left ventricular remodeling after myocardial infarction.
- To highlight the role of the renin-angiotensin-aldosterone system (RAAS) activation.
- To discuss the therapeutic application of ACE inhibitors in post-infarct care.
Summary:
- Left ventricular remodeling post-MI leads to decreased contractility and RAAS activation.
- ACE inhibitors have demonstrated significant mortality reduction in large randomized trials.
- Early and selective ACE inhibitor administration shows superior efficacy, particularly in heart failure patients.
Impact:
- ACE inhibitors are crucial for reducing post-myocardial infarction mortality.
- Improved adherence to evidence-based guidelines for ACE inhibitor use is needed.
- Individualized treatment strategies and high-dose therapy may offer additional benefits.